Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,957 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and Safety of Stempeucel in Osteoarthritis of the Knee: A Phase 3 Randomized, Double-Blind, Multicenter, Placebo-Controlled Study.
Gupta PK, Maheshwari S, Cherian JJ, Goni V, Sharma AK, Tripathy SK, Talari K, Pandey V, Sancheti PK, Singh S, Bandyopadhyay S, Shetty N, Kamath SU, Prahaldbhai PS, Abraham J, Kannan S, Bhat S, Parshuram S, Shahavi V, Sharma A, Verma NN, Kumar U. Gupta PK, et al. Among authors: abraham j. Am J Sports Med. 2023 Jul;51(9):2254-2266. doi: 10.1177/03635465231180323. Epub 2023 Jun 27. Am J Sports Med. 2023. PMID: 37366164 Clinical Trial.
Label extension, single-arm, phase III study shows efficacy and safety of stempeucel® in patients with critical limb ischemia due to atherosclerotic peripheral arterial disease.
Gupta PK, Shivashankar P, Rajkumar M, Mahapatra SS, Desai SC, Dhar A, Krishna V, Raviraja NS, Bhat S, Viswanathan P, Kannan S, Abraham J, Boggarapu H, Manjuprasad MS, Udaykumar K. Gupta PK, et al. Among authors: abraham j. Stem Cell Res Ther. 2023 Apr 1;14(1):60. doi: 10.1186/s13287-023-03292-w. Stem Cell Res Ther. 2023. PMID: 37005673 Free PMC article. Clinical Trial.
Phase IV postmarketing surveillance study shows continued efficacy and safety of Stempeucel in patients with critical limb ischemia due to Buerger's disease.
Gupta PK, Dutta S, Kala S, Nekkanti M, Desai SC, Mahapatra SS, Dhar A, Raju R, M R, Behera A, P S, Raviraja NS, Viswanathan P, Chandrashekar M, Thej C, K V P, Abraham J, Boggarapu H, Udaykumar K. Gupta PK, et al. Among authors: abraham j. Stem Cells Transl Med. 2021 Dec;10(12):1602-1613. doi: 10.1002/sctm.21-0197. Epub 2021 Sep 13. Stem Cells Transl Med. 2021. PMID: 34519179 Free PMC article. Clinical Trial.
Analysis of CD20 and PD-L1 levels on small extracellular vesicles (sEV) produced by DLBCL cells and EBV-transformed B cells, and potential role in T cell inhibition.
Akil H, Bentayeb H, Aitamer M, Vignoles C, Abraham J, Gachard N, Olivrie A, Guyot A, Gobbo J, Feuillard J, Shirvani H, Troutaud D. Akil H, et al. Among authors: abraham j. Exp Hematol Oncol. 2024 May 17;13(1):53. doi: 10.1186/s40164-024-00518-2. Exp Hematol Oncol. 2024. PMID: 38760788 Free PMC article.
The milk study protocol: A longitudinal, prospective cohort study of the relationship between human milk metabolic hormone concentration, maternal body composition, and early growth and satiety development in Samoan infants aged 1-4 months.
Harries V, Abraham J, Vesi L, Reupena A, Faaselele-Savusa K, Duckham RL, Bribiescas R, Hawley N. Harries V, et al. Among authors: abraham j. PLoS One. 2024 May 10;19(5):e0292997. doi: 10.1371/journal.pone.0292997. eCollection 2024. PLoS One. 2024. PMID: 38728264 Free PMC article.
Becoming Endemic: Anaplasmosis Imported Across State Borders.
Abraham JD, Wenning HS, Saeed DA, Derbarsegian A, Brook BA, He P. Abraham JD, et al. Cureus. 2024 Apr 9;16(4):e57902. doi: 10.7759/cureus.57902. eCollection 2024 Apr. Cureus. 2024. PMID: 38725788 Free PMC article.
Heart Transplantation Patient Selection.
Brown KN, Abraham J, Ashline PT, Kanmanthareddy A. Brown KN, et al. Among authors: abraham j. 2024 May 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2024 May 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 30725775 Free Books & Documents.
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial.
Burris HA 3rd, Okusaka T, Vogel A, Lee MA, Takahashi H, Breder V, Blanc JF, Li J, Bachini M, Żotkiewicz M, Abraham J, Patel N, Wang J, Ali M, Rokutanda N, Cohen G, Oh DY. Burris HA 3rd, et al. Among authors: abraham j. Lancet Oncol. 2024 May;25(5):626-635. doi: 10.1016/S1470-2045(24)00082-2. Lancet Oncol. 2024. PMID: 38697156 Clinical Trial.
1,957 results